Transform Pharmacovigilance with ConvergeHEALTH Safety™ has been saved
Transform Pharmacovigilance with ConvergeHEALTH Safety™
Evidence-based drug safety software improves patient outcomes
A new paradigm for pharmacovigilance (PV) is required to address the operational and compliance challenges experienced today. Deloitte has collaborated with several industry partners and regulators to develop ConvergeHEALTH Safety—an evidence-based platform for safety intelligence—to enable an outcomes-based, patient-centric care model.
The PV industry is transforming its operating models and evolving its technologies. This shift will maximize efficiencies in the face of increased case processing and large volumes of new and traditional data sources, while also streamlining complex product portfolios and therapeutic areas.
ConvergeHEALTH Safety is a high performance, evidence-based safety software platform, built to meet pharmacovigilance needs and challenges. Our modular platform drives improved drug-risk profiles by mitigating risk and reducing cost, enabling safety professionals to focus on high-value opportunities.
Improving patient outcomes with ConvergeHEALTH Safety
How Deloitte can help
Deloitte's leading life sciences practice can deliver the experience, knowledge, and technologies to help you effectively navigate the rapidly evolving world of safety software. If you're looking for professionals who understand today's PV issues and deliver innovative solutions, let's talk.